Drugs / Gynostemma pentaphyllum
last change Mar 2023 re-read 3 minutes ago

Gynostemma pentaphyllum

Developed for
metabolic syndrome X
Investigated by
First Affiliated Hospital Xi'an Jiaotong University

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT05118698 Mar → Oct 2022 metabolic syndrome X First Affiliated Hospital Xi'an Jiaotong University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gynostemma pentaphyllum “Participants will be allowed to drink Gynostemma pentaphyllum powder containing 12% saponin, 2 g each time, 3 times a day for 3 months.” NCT05118698 ↗
Route Oral “drink Gynostemma pentaphyllum powder” NCT05118698 ↗